$37.4 Million
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$57.5 Million
Catalyst Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$250.0 Million
Prothena Corporation plc
At the Market Offering
Left Bookrunner
$650.0 Million
BridgeBio Pharma, Inc.
Convertible Offering
Passive Bookrunner
$50.0 Million
ImmunoVaccine (IMV, Inc.)
At the Market Offering
Active Bookrunner
$40.0 Million
Aptose Biosciences Inc.
At the Market Offering
Sole Placement Agent
$30.0 Million
ImmunoVaccine (IMV, Inc.)
At the Market Offering
Active Bookrunner
$100.0 Million
Recro Pharma, Inc.
Mezzanine Debt
Financial Advisor
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. reverse merged with PDS Biotechnology Corporation
Financial Advisor
$15.7 Million
Acer Therapeutics Inc.
Acer Therapeutics has executed a PIPE and reverse merger with Opexa Therapeutics, Inc.
Financial Advisor
Subscribe to Biopharma

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.